Immature mice are more susceptible than adult mice to acetaminophen-induced acute liver injury

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Lu, Yan ^a   Zhang, Cheng ^a   Chen, Yuan Hua ^a   Wang, Hua ^a   Zhang, Zhi Hui ^a   Chen, Xi ^a   Xu, De Xiang ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CYP3A11 PROTEIN, MOUSE; CYTOCHROME P-450 2E1, MOUSE; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; GLUTATHIONE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MEMBRANE PROTEIN; PARACETAMOL; RALBP1 PROTEIN, MOUSE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, MOUSE;

ANIMAL; DRUG EFFECT; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; LIVER; MALE; METABOLISM; MOUSE; PATHOLOGY; TOXIC HEPATITIS;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; CHEMICAL AND DRUG INDUCED LIVER INJURY; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 CYP3A; FEMALE; GLUTATHIONE; GTPASE-ACTIVATING PROTEINS; LIVER; MALE; MEMBRANE PROTEINS; MICE; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 85012960871     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42736     Document Type: Article

References (45)

1. Beger, R. D. et al. Translational biomarkers of acetaminophen-induced acute liver injury. Arch. Toxicol. 89, 1497-1522 (2015).
2. Jaeschke, H., McGill, M. R. & Ramachandran, A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab. Rev. 44, 88-106 (2012).
3. Maes, M., Vinken, M. & Jaeschke, H. Experimental models of hepatotoxicity related to acute liver failure. Toxicol. Appl. Pharmacol. 290, 86-97 (2016).
4. Chen, W. et al. Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chem. Res. Toxicol. 11, 295-301 (1998).
5. Hartman, J. H. et al. Cooperativity in CYP2E1 metabolism of acetaminophen and styrene mixtures. Biochem. Pharmacol. 97, 341-349 (2015).
6. Zaher, H. et al. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol. Appl. Pharmacol. 152, 193-199 (1998).
7. Manyike, P. T., Kharasch, E. D., Kalhorn, T. F. & Slattery, J. T. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin. Pharmacol. Ther. 67, 275-282 (2000).
8. Guo, G. L. et al. Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol. Sci. 82,374-380 (2004).
9. Laine, J. E., Auriola, S., Pasanen, M. & Juvonen, R. O. Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. Xenobiotica. 39, 11-21 (2009).
10. Thummel, K. E., Lee, C. A., Kunze, K. L., Nelson, S. D. & Slattery, J. T. Oxidation of acetaminophen to N-acetyl-paminobenzoquinone imine by human CYP3A4. Biochem. Pharmacol. 45, 1563-1569 (1993).
11. Gunawan, B. K. et al. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 131, 165-178 (2006).
12. Latchoumycandane, C., Goh, C. W., Ong, M. M. & Boelsterli, U. A. Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. Hepatology 45, 412-421 (2007).
13. Bajt, M. L., Cover, C., Lemasters, J. J. & Jaeschke, H. Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury. Toxicol. Sci. 94, 217-225 (2006).
14. Bajt, M. L. et al. Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity. Toxicol. Sci. 122, 598-605 (2011).
15. Deutsch, M. et al. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis. 6, e1759 (2015).
16. Dara, L. et al. Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis. Hepatology 62, 1847-1857 (2015).
17. Zhang, Y. F. et al. Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice. Toxicol. Lett. 225, 445-453 (2014).
18. Ramachandran, A. et al. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology. 58, 2099-2108 (2013).
19. Marzuillo, P., Guarino, S. & Barbi, E. Paracetamol: a focus for the general pediatrician. Eur. J. Pediatr. 173, 415-425 (2014).
20. Blackford, M. G., Felter, T., Gothard, M. D. & Reed, M. D. Assessment of the clinical use of intravenous and oral N-acetylcysteine in the treatment of acute acetaminophen poisoning in children: a retrospective review. Clin. Ther. 33, 1322-1330 (2011).
21. Leonis, M. A. et al. Chronic acetaminophen exposure in pediatric acute liver failure. Pediatrics 131, e740-746 (2013).
22. Murray, K. F., Hadzic, N., Wirth, S., Bassett, M. & Kelly, D. Drug-related hepatotoxicity and acute liver failure. J. Pediatr. Gastroenterol. Nutr. 47, 395-405 (2008).
23. Squires, R. H. Jr. et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J. Pediatr. 148, 652-658 (2006).
24. Savino, F. et al. Fulminant hepatitis after 10 days of acetaminophen treatment at recommended dosage in an infant. Pediatrics 127, e494-497 (2011).
25. Mach. J. et al. The effect of aging on acetaminophen pharmacokinetics, toxicity and Nrf2 in Fischer 344 rats. J. Gerontol. A Biol. Sci. Med. Sci. 69, 387-397 (2014).
26. Hanawa, N. et al. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminopheninduced liver injury. J. Biol. Chem. 283, 13565-13577 (2008).
27. Yang, X., Chao, X., Wang, Z. T. & Ding, W. X. The end of RIPK1-RIPK3-MLKL-mediated necroptosis in acetaminophen-induced hepatotoxicity Hepatology 64, 311-312 (2016).
28. Schneider, A. T., Gautheron, J., Tacke, F., Vucur, M. & Luedde, T. Receptor interacting protein kinase 1 (RIPK1) in hepatocytes does not mediate murine acetaminophen toxicity. Hepatology 64, 306-308 (2016).
29. Coen, M. Metabolic phenotyping applied to pre-clinical and clinical studies of acetaminophen metabolism and hepatotoxicity. Drug Metab. Rev. 47, 29-44 (2015).
30. Hinson, J. A., Reid, A. B., McCullough, S. S. & James, L. P. Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab. Rev. 36, 805-822 (2004).
31. McGill, M. R. & Jaeschke, H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm. Res. 30, 2174-2187 (2013).
32. Wu, G., Fang, Y. Z., Yang, S., Lupton, J. R. & Turner, N. D. Glutathione metabolism and its implications for health. J. Nutr. 134, 489-492 (2004).
33. Abdelmegeed, M. A., Moon, K. H., Chen, C., Gonzalez, F. J. & Song, B. J. Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochem. Pharmacol. 79, 57-66 (2010).
34. Kim, N. D., Kwak, M. K. & Kim, S. G. Inhibition of cytochrome P450 2E1 expression by 2-(allylthio)pyrazine, a potential chemoprotective agent: hepatoprotective effects. Biochem. Pharmacol. 53, 261-269 (1997).
35. Li, Y. et al. Effects of phenethyl isothiocyanate on acetaminophen metabolism and hepatotoxicity in mice. Toxicol. Appl. Pharmacol. 144, 306-314 (1997).
36. Wang, E. J. et al. Protective effects of garlic and related organosulfur compounds on acetaminophen-induced hepatotoxicity in mice. Toxicol. Appl. Pharmacol. 136, 146-154 (1996).
37. Sinclair, J. et al. Alcohol-mediated increases in acetaminophen hepatotoxicity: role of CYP2E and CYP3A. Biochem. Pharmacol. 55, 1557-1565 (1998).
38. Thummel, K. E. et al. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin. Pharmacol. Ther. 67, 591-599 (2000).
39. Wolf, K. K. et al. Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wildtype and Cyp2e1(-/-) mice. Drug Metab. Dispos. 35, 1223-1231 (2007).
40. Du, K., Williams, C. D., McGill, M. R. & Jaeschke, H. Lower susceptibility of female mice to acetaminophen hepatotoxicity: Role of mitochondrial glutathione, oxidant stress and c-jun N-terminal kinase. Toxicol. Appl. Pharmacol. 281, 58-66 (2014).
41. Anderson, M. E. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113, 548-555 (1985).
42. Ferlini, A. & Rimessi, P. Exon skipping quantification by real-time PCR. Methods Mol. Biol. 867, 189-199 (2012).
43. Hoebeeck, J., Speleman, F. & Vandesompele, J. Real-time quantitative PCR as an alternative to Southern blot or fluorescence in situ hybridization for detection of gene copy number changes. Methods Mol. Biol. 353, 205-226 (2007).
44. Paglia, D. E. & Valentine, W. N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70, 158-169 (1967).
45. Habig, W. H. & Jakoby, W. B. Assays for differentiation of glutathione S-transferases. Methods Enzymol. 77, 398-405 (1981).